Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

Keyphrases

• Aberrations 100%
• Anandamide 33%
• Antagonistic Effect 33%
• Antioxidant Response Element 33%
• Bipolar Disorder 33%
• Calcium Homeostasis 33%
• Cannabidiol 33%
• Cannabinoid Receptor 1 (CB1R) 33%
• Cannabinoid Receptor 2 33%
• CNR1 33%
• CNR2 33%
• Cysteine 33%
• Cytokine Levels 33%
• Dimethyl Fumarate 33%
• DNA Methylation (DNAm) 33%
• Endocannabinoid System 100%
• Endocannabinoids 33%
• Fatty Acid Amide Hydrolase 66%
• Hydrolase Activity 33%
• Immune-inflammatory Response 33%
• Increased Activity 33%
• Inflammation 33%
• Inflammatory Cytokines 33%
• Inflammatory Pathways 33%
• Major Depressive Disorder 33%
• Metabolism 33%
• MicroRNA 33%
• MiR-139 33%
• Monoacylglycerol Lipase 100%
• Mood Disorders 100%
• N-acyltransferase 33%
• NADPH Oxidase 4 (NOX4) 33%
• Negative Feedback Loop 33%
• Neurobiological Mechanisms 33%
• Neuropsychiatric Disorders 33%
• Nitration 33%
• Nitrosative Stress 100%
• NOX1 33%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 33%
• Oxidative Inflammation 100%
• Oxidative Stress 33%
• Phospholipase A2 Activity 33%
• Promoter Region 33%
• Redox Signaling 33%
• S-nitrosylation 33%
• Schizophrenia 100%
• Therapeutic Potential 33%
• Through Effect 66%
• Transcription Factor 33%
• Tyrosine Residue 33%

Biochemistry, Genetics and Molecular Biology

• Anandamide 25%
• Antioxidant Responsive Element 25%
• Calcium Homeostasis 25%
• Cannabidiol 25%
• Cannabinoid Receptor 25%
• Cysteine 25%
• Diacylglycerol Lipase 25%
• DNA Methylation 25%
• Endocannabinoid System 100%
• Enzyme 25%
• Fatty Acid Amide Hydrolase 50%
• Metabolic Pathway 25%
• MicroRNA 25%
• Monoacylglycerol Lipase 50%
• N-Acetyltransferase 25%
• NAD(P)H Oxidase 25%
• Nitrosylation 25%
• NOX1 25%
• NOX4 25%
• Oxidative Stress 100%
• Phospholipase A2 25%
• Proinflammatory Cytokine 25%
• Promoter Region 25%
• Transcription Factor Nrf2 25%
• Tyrosine 25%
• Upregulation 25%